Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 2
2003 1
2008 1
2009 1
2010 3
2011 4
2012 2
2013 1
2014 1
2015 5
2016 1
2017 1
2018 2
2019 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

26 results
Results by year
Filters applied: . Clear all
Page 1
VEGFC Antibody Therapy Drives Differentiation of AML.
Kampen KR, Scherpen FJG, Mahmud H, Ter Elst A, Mulder AB, Guryev V, Verhagen HJMP, De Keersmaecker K, Smit L, Kornblau SM, De Bont ESJM. Kampen KR, et al. Among authors: scherpen fjg. Cancer Res. 2018 Oct 15;78(20):5940-5948. doi: 10.1158/0008-5472.CAN-18-0250. Epub 2018 Sep 5. Cancer Res. 2018. PMID: 30185550 Free article.
Identification of Two Protein-Signaling States Delineating Transcriptionally Heterogeneous Human Medulloblastoma.
Zomerman WW, Plasschaert SLA, Conroy S, Scherpen FJ, Meeuwsen-de Boer TGJ, Lourens HJ, Guerrero Llobet S, Smit MJ, Slagter-Menkema L, Seitz A, Gidding CEM, Hulleman E, Wesseling P, Meijer L, van Kempen LC, van den Berg A, Warmerdam DO, Kruyt FAE, Foijer F, van Vugt MATM, den Dunnen WFA, Hoving EW, Guryev V, de Bont ESJM, Bruggeman SWM. Zomerman WW, et al. Among authors: scherpen fj. Cell Rep. 2018 Mar 20;22(12):3206-3216. doi: 10.1016/j.celrep.2018.02.089. Cell Rep. 2018. PMID: 29562177 Free article.
CREB signaling activity correlates with differentiation and survival in medulloblastoma.
Armandari I, Zomerman WW, Plasschaert SLA, Smit MJ, Martini TEI, de Camargo Magalhães ES, Hogeling SM, Rozema-Huizinga GC, Lourens HJ, Meeuwsen-de Boer TGJ, Scherpen FJG, de Bont ESJM, Bruggeman SWM. Armandari I, et al. Among authors: scherpen fjg. Sci Rep. 2021 Aug 9;11(1):16077. doi: 10.1038/s41598-021-95381-0. Sci Rep. 2021. PMID: 34373489 Free PMC article.
Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC.
Wei J, Meng P, Terpstra MM, van Rijk A, Tamminga M, Scherpen F, Ter Elst A, Alimohamed MZ, Johansson LF, Stigt J, Gijtenbeek RPG, van Putten J, Hiltermann TJN, Groen HJM, Kok K, van der Wekken AJ, van den Berg A. Wei J, et al. Among authors: scherpen f. Target Oncol. 2021 Mar;16(2):215-226. doi: 10.1007/s11523-021-00798-2. Epub 2021 Feb 19. Target Oncol. 2021. PMID: 33606136 Free PMC article.
MBL2 and fever during neutropenia in children with acute lymphoblastic leukaemia.
te Poele EM, Siedlinski M, Anne de Pagter PJ, Bierings MB, Scherpen FJ, Meeuwsen-de Boer TG, Koppelman GH, Postma DS, Kamps WA, Boezen HM, de Bont ES. te Poele EM, et al. Among authors: scherpen fj. Br J Haematol. 2012 Apr;157(1):132-5. doi: 10.1111/j.1365-2141.2011.08912.x. Epub 2011 Nov 3. Br J Haematol. 2012. PMID: 22050689 Clinical Trial. No abstract available.
EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System.
Kampen KR, Scherpen FJ, Garcia-Manero G, Yang H, Kaspers GJ, Cloos J, Zwaan CM, van den Heuvel-Eibrink MM, Kornblau SM, De Bont ES. Kampen KR, et al. Among authors: scherpen fj. Mol Cancer Res. 2015 Jun;13(6):982-92. doi: 10.1158/1541-7786.MCR-14-0660-T. Epub 2015 May 5. Mol Cancer Res. 2015. PMID: 25944917 Free PMC article.
26 results